Effects of exenatide (Exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
This may be related to rapid weight loss or changes in bile composition
Back Klausen, MK, Jensen, ME, Mller, M, et al (6 Sept 2022) 'Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial', JCI Insight, 7/19, e159863
Results vary, but studies show that individuals using Semaglutide for weight loss can lose an average of 10-15% of their body weight over time
The medication works through a dual mechanism of action that targets two incretin hormone pathways simultaneously